相似文献
1
Long-lasting remission induced by rituximab in two cases of refractory autoimmune haemolytic anaemia due to cold agglutinins.
Blood Transfus. 2009 Jul;7(3):235-6. doi: 10.2450/2008.0066-08.
2
Long lasting remission by rituximab in a patient with primary cold agglutinin autoimmune haemolytic anaemia.
Wien Klin Wochenschr. 2011 Nov;123(21-22):680-3. doi: 10.1007/s00508-011-0060-6. Epub 2011 Sep 28.
3
Rituximab: a very efficient therapy in cold agglutinins and refractory autoimmune haemolytic anaemia associated with CD20-positive, low-grade non-Hodgkin's lymphoma.
Br J Haematol. 2001 Mar;112(4):1085-6. doi: 10.1046/j.1365-2141.2001.02622-3.x.
4
Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-CD20 monoclonal antibody rituximab.
Clin Lab Haematol. 2006 Feb;28(1):57-9. doi: 10.1111/j.1365-2257.2006.00738.x.
5
Treatment of childhood autoimmune haemolytic anaemia with rituximab.
Lancet. 2001 Nov 3;358(9292):1511-3. doi: 10.1016/s0140-6736(01)06573-4.
6
Daratumumab in rituximab-refractory autoimmune haemolytic anaemia.
Br J Haematol. 2021 Sep;194(5):931-934. doi: 10.1111/bjh.17655. Epub 2021 Jun 28.
7
Anti-CD20 monoclonal antibody (rituximab) therapy in a child with refractory chronic autoimmune haemolytic anaemia.
Intern Med J. 2003 Nov;33(11):544-5. doi: 10.1046/j.1445-5994.2003.00457.x.
8
Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias.
Blood. 2010 Dec 2;116(23):4783-5. doi: 10.1182/blood-2010-06-291831. Epub 2010 Sep 14.
9
Treatment of refractory autoimmune haemolytic anaemia with anti-CD20 (rituximab).
Br J Haematol. 2001 Jul;114(1):244-5. doi: 10.1046/j.1365-2141.2001.02873-4.x.
10
A case of autoimmune haemolytic anaemia achieving complete response with rituximab.
J Pak Med Assoc. 2014 Jun;64(6):700-2.
引用本文的文献
1
Rituximab in the treatment of autoimmune haemolytic anaemia.
Br J Clin Pharmacol. 2015 May;79(5):709-19. doi: 10.1111/bcp.12498.
2
Occurrence of lymphoplasmacytic lymphoma 6 years after amelioration of primary cold agglutinin disease by rituximab therapy.
Int J Hematol. 2012 Oct;96(4):501-5. doi: 10.1007/s12185-012-1158-y. Epub 2012 Aug 11.
3
Long lasting remission by rituximab in a patient with primary cold agglutinin autoimmune haemolytic anaemia.
Wien Klin Wochenschr. 2011 Nov;123(21-22):680-3. doi: 10.1007/s00508-011-0060-6. Epub 2011 Sep 28.
4
Cold autoimmune hemolytic anemia resolved by rituximab.
Asian J Transfus Sci. 2010 Jul;4(2):136-7. doi: 10.4103/0973-6247.67027.
本文引用的文献
1
Cost-effectiveness of rituximab in refractory cold agglutinin disease.
Int J Lab Hematol. 2008 Aug;30(4):331-3. doi: 10.1111/j.1751-553X.2007.00958.x.
2
Cold antibody autoimmune hemolytic anemias.
Blood Rev. 2008 Jan;22(1):1-15. doi: 10.1016/j.blre.2007.08.002. Epub 2007 Sep 27.
3
Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients.
Leuk Lymphoma. 2006 Feb;47(2):253-60. doi: 10.1080/10428190500286481.
4
Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients.
Blood. 2004 Apr 15;103(8):2925-8. doi: 10.1182/blood-2003-10-3597. Epub 2003 Dec 30.
5
Beneficial effects of rituximab on primary cold agglutinin disease refractory to conventional therapy.
Eur J Haematol. 2002 Apr;68(4):243-6. doi: 10.1034/j.1600-0609.2002.01667.x.
Zotero 插件